DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,388,000 | +6.4% | 9,418 | +23.1% | 0.17% | +18.6% |
| Q1 2022 | $2,244,000 | -2.3% | 7,651 | +9.5% | 0.14% | -2.0% |
| Q4 2021 | $2,298,000 | +16.7% | 6,986 | +8.0% | 0.15% | +5.0% |
| Q3 2021 | $1,969,000 | +15.1% | 6,466 | +1.5% | 0.14% | +12.8% |
| Q2 2021 | $1,710,000 | +23.7% | 6,371 | +3.8% | 0.12% | +12.6% |
| Q1 2021 | $1,382,000 | +10.2% | 6,139 | +8.7% | 0.11% | 0.0% |
| Q4 2020 | $1,254,000 | +9.4% | 5,647 | +6.1% | 0.11% | -6.7% |
| Q3 2020 | $1,146,000 | +29.9% | 5,323 | +6.7% | 0.12% | +20.2% |
| Q2 2020 | $882,000 | +85.3% | 4,987 | +45.1% | 0.10% | +52.3% |
| Q1 2020 | $476,000 | +18.4% | 3,438 | +31.3% | 0.06% | +35.4% |
| Q4 2019 | $402,000 | +2.8% | 2,619 | -3.3% | 0.05% | -9.4% |
| Q3 2019 | $391,000 | +2.9% | 2,708 | +2.0% | 0.05% | -3.6% |
| Q2 2019 | $380,000 | +7.3% | 2,656 | -1.0% | 0.06% | -1.8% |
| Q1 2019 | $354,000 | +21.2% | 2,684 | -5.1% | 0.06% | 0.0% |
| Q4 2018 | $292,000 | -1.7% | 2,827 | +3.6% | 0.06% | -1.8% |
| Q3 2018 | $297,000 | +0.7% | 2,729 | -8.8% | 0.06% | -27.8% |
| Q2 2018 | $295,000 | – | 2,993 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |